Researchers have conducted the first human trial of an under-the-skin microchip device that aims to replace daily injection for osteoporosis patients.

Researchers in Cambridge, alongside scientists from MicroCHIPS Inc, implanted the microchip-based drug delivery device containing osteoporosis treatment under the skins of eight women with the problem, and controlled them wirelessly to release daily doses of medicine for the patients.

Following the successful completion of the trial, the microchip devices were safely removed from the volunteers’ bodies.

Trial showed that the daily release of medicine from devices boosted bone formation without any toxic and negative results.

At a meeting in British Columbia, of the American Association for the Advancement of Science, researchers reported that the implants didn’t impact the quality of life of patients.

Prof. Robert Langer, the senior author of the study, said, "You can do remote control delivery, you can do pulsatile drug delivery, and you can deliver multiple drugs.”

The microchip-based drug delivery device is expected to become a cost-effective alternative to daily injections in the near future.